HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutations in Turnip mosaic virus P3 and cylindrical inclusion proteins are separately required to overcome two Brassica napus resistance genes.

Abstract
The Brassica napus differential line 165 is resistant to infection by Turnip mosaic virus (TuMV) isolates belonging to pathotypes 1 and 3. Nucleotide sequences of resistance-breaking mutants of pathotype 1 (UK 1), pathotype 3 (CHN 12), and wild-type isolates have been determined. When the mutations identified were introduced into an infectious clone of UK 1, a single mutation in the viral P3 protein induced a hypersensitive (necrotic) response in inoculated leaves of line 165 plants. Full systemic nonnecrotic infection was only possible when another mutation (in the cylindrical inclusion protein) was introduced. Tests on segregating populations derived from line 165 indicated that the two viral genes were pathogenicity determinants for two different resistance genes in line 165. One gene responsible for an extreme form of resistance (no symptoms seen) was epistatic to a second responsible for the hypersensitive reaction. These results help to explain the relative stability of the resistance in line 165 and to further define the genetic basis of the TuMV pathotyping system.
AuthorsCarol E Jenner, Kenta Tomimura, Kazusato Ohshima, Sara L Hughes, John A Walsh
JournalVirology (Virology) Vol. 300 Issue 1 Pg. 50-9 (Aug 15 2002) ISSN: 0042-6822 [Print] United States
PMID12202205 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Base Sequence
  • Brassica napus (genetics, virology)
  • Immunity, Innate (genetics)
  • Mutation
  • Plant Diseases (virology)
  • Plant Leaves (virology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tymovirus (genetics, pathogenicity)
  • Virulence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: